As America’s population continues to age, there’s more need than ever for increased access to diagnosis and treatment of rheumatic diseases. Consider that approximately 50 million Americans, or one in five adults, suffer from rheumatoid arthritis, lupus or other autoimmune diseases. Women are more likely than men to be affected, with some estimates indicating that 75 percent of those affected — some 37 million people — are female.